Dr. LeBoeuf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
221 Longwood Ave
Boston, MA 02115Phone+1 617-732-4918Fax+1 617-582-6060- Is this information wrong?
Education & Training
- University of Massachusetts Medical SchoolClass of 2006
Certifications & Licensure
- ME State Medical License Current
- MA State Medical License 2010 - 2025
- NY State Medical License 2008 - 2014
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study.Semenov, Y. R., Guihong Wan, Sara Khattab, Bonnie W Leung, Shijia Zhang, Nga Nguyen, Matthew Tran, Chuck Lin, Crystal Chang, Nora Alexander, Ruple Jairath, Jordan Phil...> ;The British Journal of Dermatology. 2024 Feb 15
- Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study.Zoltan Maliga, Daniel Y Kim, Ai-Tram N Bui, Jia-Ren Lin, Anna K Dewan, Saagar Jadeja, George F Murphy, Ajit J Nirmal, Christine G Lian, Peter K Sorger, Nicole R LeBoeuf> ;The Journal of Investigative Dermatology. 2024 Feb 14
- Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study.Rashdan, H., Zhang, S., Wan, G., Nguyen, N., Roster, K., Rajeh, A., Tang, K., Chen, W., Moseley, C., Chen, S., LeBoeuf, N., Semenov, Y.> ;Journal of the American Academy of Dermatology. 2024 Jan 28
- Join now to see all
Press Mentions
- Oral Retinoid May Ease Painful Skin Reactions to Anticancer TherapyMay 13th, 2022
- Despite Decades of Promises, Health Research Still Overlooks Women | Medical ResearchNovember 21st, 2023
- Predicting Immune-Related Adverse Events from Checkpoint Inhibitors in MelanomaDecember 29th, 2023
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: